These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 31489705)
21. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels. Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment. Wollenweber FA; Därr S; Müller C; Duering M; Buerger K; Zietemann V; Malik R; Brendel M; Ertl-Wagner B; Bartenstein P; Rominger A; Dichgans M Stroke; 2016 Oct; 47(10):2645-8. PubMed ID: 27539301 [TBL] [Abstract][Full Text] [Related]
23. Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype. Bangen KJ; Clark AL; Werhane M; Edmonds EC; Nation DA; Evangelista N; Libon DJ; Bondi MW; Delano-Wood L; J Alzheimers Dis; 2016 Mar; 52(3):849-61. PubMed ID: 27031472 [TBL] [Abstract][Full Text] [Related]
24. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Cho H; Choi JY; Hwang MS; Kim YJ; Lee HM; Lee HS; Lee JH; Ryu YH; Lee MS; Lyoo CH Ann Neurol; 2016 Aug; 80(2):247-58. PubMed ID: 27323247 [TBL] [Abstract][Full Text] [Related]
25. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE). Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768 [TBL] [Abstract][Full Text] [Related]
26. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging. Hatashita S; Wakebe D J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292 [TBL] [Abstract][Full Text] [Related]
27. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment. Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417 [TBL] [Abstract][Full Text] [Related]
28. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H; Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152 [TBL] [Abstract][Full Text] [Related]
29. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia. Rabinovici GD; Gatsonis C; Apgar C; Chaudhary K; Gareen I; Hanna L; Hendrix J; Hillner BE; Olson C; Lesman-Segev OH; Romanoff J; Siegel BA; Whitmer RA; Carrillo MC JAMA; 2019 Apr; 321(13):1286-1294. PubMed ID: 30938796 [TBL] [Abstract][Full Text] [Related]
30. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment. Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054 [TBL] [Abstract][Full Text] [Related]
31. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment. Yatawara C; Lim L; Chander R; Zhou J; Kandiah N J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200 [TBL] [Abstract][Full Text] [Related]
32. Association between white matter lesions and cerebral Aβ burden. Yi HA; Won KS; Chang HW; Kim HW PLoS One; 2018; 13(9):e0204313. PubMed ID: 30248123 [TBL] [Abstract][Full Text] [Related]
34. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA; Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397 [TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance image-based brain age as a discriminator of dementia conversion in patients with amyloid-negative amnestic mild cognitive impairment. Kim HW; Kim HJ; Lee H; Yang H; Rieu Z; Lee JH Sci Rep; 2023 Dec; 13(1):22467. PubMed ID: 38105274 [TBL] [Abstract][Full Text] [Related]
36. Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment. Kim HJ; Cheong EN; Jo S; Lee S; Shim WH; Kang DW; Kwon M; Kim JS; Lee JH Alzheimer Dis Assoc Disord; 2021 Oct-Dec 01; 35(4):298-305. PubMed ID: 34132669 [TBL] [Abstract][Full Text] [Related]
37. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort. Dufouil C; Dubois B; Vellas B; Pasquier F; Blanc F; Hugon J; Hanon O; Dartigues JF; Harston S; Gabelle A; Ceccaldi M; Beauchet O; Krolak-Salmon P; David R; Rouaud O; Godefroy O; Belin C; Rouch I; Auguste N; Wallon D; Benetos A; Pariente J; Paccalin M; Moreaud O; Hommet C; Sellal F; Boutoleau-Bretonniére C; Jalenques I; Gentric A; Vandel P; Azouani C; Fillon L; Fischer C; Savarieau H; Operto G; Bertin H; Chupin M; Bouteloup V; Habert MO; Mangin JF; Chêne G; Alzheimers Res Ther; 2017 Aug; 9(1):67. PubMed ID: 28851447 [TBL] [Abstract][Full Text] [Related]
38. Characteristics of neurocognitive functions in mild cognitive impairment with depression. Dong HS; Han C; Jeon SW; Yoon S; Jeong HG; Huh YJ; Pae CU; Patkar AA; Steffens DC Int Psychogeriatr; 2016 Jul; 28(7):1181-90. PubMed ID: 26960534 [TBL] [Abstract][Full Text] [Related]
39. Brain Amyloid Deposition Is Associated With Lower Instrumental Activities of Daily Living Abilities in Older Adults. Results From the MAPT Study. Lilamand M; Cesari M; del Campo N; Cantet C; Soto M; Ousset PJ; Payoux P; Andrieu S; Vellas B; J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):391-7. PubMed ID: 26419979 [TBL] [Abstract][Full Text] [Related]
40. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]